Treatment paradigms in hepatitis B e antigen negative (HBeAg-negative) chronic hepatitis B patients

被引：0
|
作者：
Hadziyannis, S. J. [1 ]
机构：
[1] Henry Dunant Hosp, Athens, Greece
来源：
JOURNAL OF CLINICAL VIROLOGY | 2006年 / 36卷
关键词：
D O I：
10.1016/S1386-6532(06)80055-7
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：S15 / S15
页数：1
相关论文
共 50 条
  • [21] Are we ready to use the hepatitis B surface antigen level to guide peginterferon treatment in HBeAg-negative chronic hepatitis B?
    Chan, Henry Lik Yuen
    [J]. HEPATOLOGY INTERNATIONAL, 2013, 7 (01) : 13 - 15
  • [22] Hepatitis B core-related antigen monitoring during peginterferon alfa treatment for HBeAg-negative chronic hepatitis B
    van Campenhout, Margo J. H.
    Rijckborst, Vincent
    Brouwer, Willem Pieter
    van Oord, Gertine W.
    Ferenci, Peter
    Tabak, Fehmi
    Akdogan, Meral
    Pinarbasi, Binnur
    Simon, Krzysztof
    de Knegt, Robert J.
    Boonstra, Andre
    Janssen, Harry L. A.
    Hansen, Bettina E.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2019, 26 (10) : 1156 - 1163
  • [23] Are we ready to use the hepatitis B surface antigen level to guide peginterferon treatment in HBeAg-negative chronic hepatitis B?
    Henry Lik Yuen Chan
    [J]. Hepatology International, 2013, 7 : 13 - 15
  • [24] HBeAg-negative chronic hepatitis
    Ibragimova, MM
    Krel, PE
    Abdurakhmanov, DT
    [J]. TERAPEVTICHESKII ARKHIV, 2004, 76 (02): : 87 - 91
  • [25] Treatment of HBeAg-negative chronic hepatitis B patients with nucleos(t)ide analogues
    Papatheodoridis, George V.
    [J]. LIVER INTERNATIONAL, 2011, 31 : 95 - 103
  • [26] Predictors of response to pegylated interferon treatment in HBeAg-negative patients with chronic hepatitis B
    Guclu, Ertugrul
    Tuna, Nazan
    Karabay, Oguz
    Akhan, Sila
    Bodur, Hurrem
    Ceylan, Bahadir
    Demirdal, Tuna
    Demirdag, Kutbettin
    Demirturk, Nese
    Ekerbicer, Hasan
    Erol, Serpil
    Esen, Saban
    Evirgen, Omer
    Geyik, Mehmet Faruk
    Gunduz, Alper
    Karahocagil, Mustafa Kasim
    Kokoglu, Omer Faruk
    Ozdemir, Davut
    Ozgunes, Nail
    Sargin, Fatma
    Tosun, Selma
    Tutuncu, Ediz
    [J]. JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2014, 8 (12): : 1601 - 1608
  • [27] Rate and determinants of antiviral treatment initiation for patients with HBeAg-negative chronic hepatitis B
    Mutimer, David
    Elsharkawy, Ahmed
    Hathorn, Emma
    Arunkumar, Selvi
    [J]. JOURNAL OF VIRAL HEPATITIS, 2023, 30 (08) : 694 - 699
  • [28] Evaluation of Hepatitis B Viraemia Levels in Patients with HBeAg-negative Chronic Hepatitis B Virus Infection
    Atay, A. E.
    Seven, G.
    Yalcin, K.
    Pasa, S.
    Degertekin, H.
    [J]. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2012, 40 (05) : 1891 - 1896
  • [29] Serum hepatitis B core-related antigen is an effective tool to categorize patients with HBeAg-negative chronic hepatitis B
    Loggi, Elisabetta
    Vukotic, Ranka
    Conti, Fabio
    Grandini, Elena
    Gitto, Stefano
    Cursaro, Carmela
    Galli, Silvia
    Furlini, Giuliano
    Re, Maria Carla
    Andreone, Pietro
    [J]. JOURNAL OF VIRAL HEPATITIS, 2019, 26 (05) : 568 - 575
  • [30] Lamivudine treatment in HBeAg-negative chronic hepatitis B patients with low level viraemia
    Bozkaya, H
    Yurdaydin, C
    Idilman, R
    Tüzün, A
    Cinar, K
    Erkan, Ö
    Bozdayi, AM
    Erden, E
    Uzun, Y
    Cetinkaya, H
    Uzunalimoglu, Ö
    [J]. ANTIVIRAL THERAPY, 2005, 10 (02) : 319 - 325
12345